Newsletter | September 24, 2026

09.24.26 -- OPCU Special CPHI Session: Trends Shaping Advanced Therapies

 

 

The development and manufacturing landscape is evolving rapidly, creating new opportunities and challenges across drug modalities, dosage forms, and delivery technologies. Whether you're advancing complex formulations, planning for scale-up, or evaluating manufacturing strategies, staying informed on the latest approaches is critical to development success.

 

In this special Outsourced Pharma Capabilities Update (OPCU) CPHI edition, industry experts will share insights into today's most pressing formulation and manufacturing considerations, from enhancing product performance and overcoming development hurdles to improving scalability and commercial readiness.

 

Explore the presentations featured in this edition of OPCU and discover practical strategies, emerging technologies, and expert perspectives designed to support your next development program.

 

Recent Sessions Available On-Demand                       
Cell Therapy & Cell Line Development – July 2026                   
ADCs And Microbial Development & Manufacturing – July 2026          
Cell Line Development – August 2026     
Nanoparticles & Solid Dose Formulation Insights – September 2026

 

Upcoming OPCU Topics & Times     
ADCs | 9/11/2026, AM Session                     
AI Innovation in Drug Development & Manufacturing | 9/29/2026, AM Session                     
Viral Vectors | 9/29/2026, PM Session                     
mRNA | 9/30/2026, AM Session                     
Packaging, Labeling, & Logistics Services | 9/30/2026, PM Session            

 

Access more on-demand OPCU recordings and upcoming sessions here.

CPHI

Thermo Fisher Scientific

Learn how connected manufacturing, logistics, and clinical capabilities can help keep your development program on track from concept to commercialization.

Request Information

Thermo Fisher Scientific

Almac Pharma Services

With 55+ years of experience, Almac Pharma Services delivers integrated CDMO solutions spanning development, manufacturing, packaging, product launch, and global supply chain support.

Request Information

Almac Pharma Services

BE Biosol

BE BioSol combines 70+ years of biopharma manufacturing expertise with an integrated biologics CDMO platform, supporting global partners from development through commercial production.

Request Information

BE Biosol

Bora Pharmaceuticals

Explore how manufacturing networks, strategic investments, and tech transfer partnerships can accelerate timelines, secure capacity, and strengthen supply chain resilience.

Request Information

Bora Pharmaceuticals

Cambrex

Dan Bowles will discuss Cambrex’s small-volume commercial API manufacturing capabilities at its High Point, North Carolina, facility.

Request Information

Cambrex

FUJIFILM Biotechnologies

See how FUJIFILM Biotechnologies’ global CDMO investments help customers accelerate development, reduce risk, and support commercial success. Join George Sakellariou for key insights. 

Request Information

FUJIFILM Biotechnologies

Jubilant HollisterStier

Advanced isolator fill lines combine 100% in-line weight checks, automated lyophilization, and flexible pumping to protect biologics, prevent API loss, and support seamless scale-up.

Request Information

Jubilant HollisterStier

Simtra Biopharma Solutions

Discover how strategic investments, advanced fill-finish capabilities, and flexible manufacturing models are helping meet growing demand for sterile drug production and long-term scalability.

Request Information

Simtra BioPharma Solutions